Estabrook Capital Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.1K Buy
2,792
+62
+2% +$921 0.01% 205
2025
Q4
$41.1K Buy
2,730
+58
+2% +$871 0.01% 197
2025
Q3
$38.5K Buy
2,672
+90
+3% +$1.28K 0.01% 200
2025
Q2
$36.8K Buy
2,582
+91
+4% +$1.3K 0.01% 199
2025
Q1
$37.1K Buy
2,491
+83
+3% +$1.3K 0.01% 197
2024
Q4
$34.7K Buy
+2,408
New +$37.3K 0.01% 208

Other funds holding BMEZ

Estabrook Capital Management's BMEZ Position: Q1 2026 in Review

Estabrook Capital Management increased its BlackRock Health Sciences Trust II (BMEZ) stake by 2.3% in Q1 2026, buying an estimated $921 and bringing the position to 2,792 shares worth $40.1K. The position accounts for 0.01% of the portfolio, ranked #205.

Estabrook Capital Management first reported a position in BMEZ in Q4 2024 and has held it in 6 quarters since. The position peaked at $41.1K in Q4 2025. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

  • Estabrook Capital Management held 2,792 shares of BlackRock Health Sciences Trust II worth $40.1K as of Q1 2026.
  • Estabrook Capital Management bought 62 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $921.
  • BlackRock Health Sciences Trust II made up 0.01% of Estabrook Capital Management's portfolio in Q1 2026, its #205 holding.
  • Estabrook Capital Management first reported a position in BlackRock Health Sciences Trust II in Q4 2024 and has held it in 6 quarters since.
  • Estabrook Capital Management's BlackRock Health Sciences Trust II position peaked at $41.1K in Q4 2025.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on Estabrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.